H Heimann Selected Research

densiron

4/2009	[Densiron-68 heavy silicone oil in cases of PVR. Anatomic and functional outcomes].
11/2008	Primary vitrectomy with Densiron-68 for rhegmatogenous retinal detachment.
10/2008	Heavy tamponade 1: a review of indications, use, and complications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Heimann Research Topics

Disease

10	Retinal Detachment (Retinal Detachments) 02/2013 - 08/2001
6	Macular Degeneration (Age-Related Maculopathy) 02/2013 - 06/2005
3	Melanoma (Melanoma, Malignant) 07/2022 - 09/2009
3	Epiretinal Membrane (Epiretinal Membranes) 02/2013 - 12/2009
2	Uveal melanoma 07/2022 - 07/2001
2	Fibrosis (Cirrhosis) 02/2013 - 07/2001
2	Retinal Vein Occlusion 09/2009 - 12/2006
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 09/2009 - 01/2005
2	Inflammation (Inflammations) 11/2008 - 10/2008
2	Dry Eye Syndromes (Dry Eye Syndrome) 11/2004 - 07/2001
2	Cataract (Cataracts) 01/2003 - 07/2001
1	Monosomy 12/2016
1	Nevus (Nevi) 12/2016
1	Retinal Perforations 02/2016
1	Neoplasms (Cancer) 12/2015
1	Hemangioma (Angioma) 02/2013
1	Arteriovenous Malformations (Arteriovenous Malformation) 02/2013
1	Intraoperative Complications 03/2011
1	Rupture 03/2011
1	Pseudophakia 10/2010
1	Vascular Malformations 03/2010
1	Endophthalmitis (Ophthalmia) 09/2009
1	Diabetic Retinopathy (Retinopathy, Diabetic) 09/2009
1	Choroid Diseases 09/2009
1	Disease Progression 09/2009
1	Choroidal Effusions 09/2009
1	Retinoschisis (Retinoschisis, Juvenile) 09/2009
1	Degenerative Myopia 09/2009
1	Necrosis 09/2009
1	Central Serous Chorioretinopathy 09/2009
1	Eye Diseases (Eye Disease) 09/2009
1	Proliferative Vitreoretinopathy 04/2009
1	Wounds and Injuries (Trauma) 03/2009
1	Choroidal Neovascularization 05/2004
1	Lymphoma (Lymphomas) 01/2004
1	Uveitis 01/2004
1	Atrophy 01/2003
1	Retinoblastoma (Glioblastoma, Retinal) 01/2003
1	Hyperpigmentation 10/2000

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 02/2013 - 10/2000
6	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2017 - 05/2004
5	Verteporfin (Visudyne)FDA Link 12/2017 - 05/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2013 - 01/2011
3	densironIBA 04/2009 - 10/2008
3	densiron-68IBA 04/2009 - 11/2008
2	SteroidsIBA 02/2013 - 01/2004
2	FluorocarbonsIBA 04/2010 - 10/2008
1	Protons (Proton)IBA 07/2022
1	Capsules (Microcapsules)IBA 03/2011
1	CytokinesIBA 10/2010
1	A-factor (Streptomyces)IBA 12/2009
1	AlkanesIBA 10/2008
1	SiliconesIBA 10/2008
1	MucinsIBA 07/2001
1	SyndecansIBA 07/2001

Therapy/Procedure

8	Therapeutics 12/2017 - 07/2001
6	Photochemotherapy (Photodynamic Therapy) 12/2017 - 05/2004
6	Vitrectomy 12/2009 - 07/2001
4	Lasers (Laser) 12/2016 - 01/2003
4	Scleral Buckling 12/2009 - 08/2001
2	Radiotherapy 07/2022 - 07/2001
2	Traction 02/2016 - 02/2013
2	Cryotherapy (Therapy, Cold) 12/2015 - 01/2005
1	Brachytherapy 07/2022
1	Proton Therapy 07/2022
1	Aftercare (After-Treatment) 12/2016
1	Vitreoretinal Surgery 09/2009
1	Cannula 03/2009
1	Solid-State Lasers 12/2006
1	Induced Hyperthermia (Thermotherapy) 01/2003
1	Drug Therapy (Chemotherapy) 01/2003